Sex differences in the case-fatality rates for COVID-19—A comparison of the age-related differences and consistency over seven countries
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Background: Early in the COVID-19 pandemic, it was noted that males seemed to have higher case-fatality rates than females. We examined the magnitude and consistency of the sex differences in age-specific case-fatality rates (CFRs) in seven countries. Methods: Data on the cases and deaths from COVID-19, by sex and age group, were extracted from the national official agencies from Denmark, England, Israel, Italy, Spain, Canada and Mexico. Age-specific CFRs were computed for males and females separately. The ratio of the male to female CFRs were computed and meta-analytic methods were used to obtained pooled estimates of the male to female ratio of the CFRs over the seven countries, for all age-groups. Meta-regression and sensitivity analysis were conducted to evaluate the age and country contribution to differences. Results: The CFRs were consistently higher in males at all ages. The pooled M:F CFR ratios were 1.71, 1.88, 2.11, 2.11, 1.84, 1.78 and 1.49, for ages 20–29, 30–39, 40–49, 50–59, 60–69, 70–79, 80+ respectively. In meta-regression, age group and country were associated with the heterogeneity in the CFR ratios. Conclusions: The sex differences in the age-specific CFRs are intriguing. Sex differences in the incidence and mortality have been found in many infectious diseases. For COVID-19, factors such as sex differences in the prevalence of underlying diseases may play a part in the CFR differences. However, the consistently greater case-fatality rates in males at all ages suggests that sex-related factors impact on the natural history of the disease. This could provide important clues as to the mechanisms underlying the severity of COVID-19 in some patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“For COVID-19, the CFR was higher for men than for women.122”
From Severe acute respiratory syndrome (SARS) mathematical models and disease parameters: a systematic review (2025) · cites this paper as [122]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552 · cited 1×
“1, and/or I(2)�50%, the random effects model [23] was used to estimate pooled CFRRs and 95% confidence intervals (CI).”
MethodCollaborative, T. O., Williamson, E., Walker, A. J., Bhaskaran, K., Bacon, S., Bates, C., Morton, C. E., Curtis, H. J., Mehrkar, A., Evans, D., et al. (2020) · doi:10.1101/2020.05.06.20092999 · Cited by 6,674
Factors associated with COVID-19-related death using OpenSAFELY
Williamson, E. J., Walker, A. J., Bhaskaran, K., Bacon, S., Bates, C., Morton, C. E., Curtis, H. J., Mehrkar, A., Evans, D., Inglesby, P., et al. (2020) · Nature · doi:10.1038/s41586-020-2521-4 · Cited by 6,674
Sex differences in immune responses
Klein, S. L., & Flanagan, K. L. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.90 · Cited by 6,370
Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan
Li, X., Xu, S., Yu, M., Wang, K., Tao, Y., Zhou, Y., Shi, J., Zhou, M., Wu, B., Yang, Z., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.04.006 · Cited by 2,219
Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis
Zheng, Z., Peng, F., Xu, B., Zhao, J., Liu, H., Peng, J., Li, Q., Jiang, C., Zhou, Y., Liu, S., et al. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.04.021 · Cited by 2,074
Molecular immune pathogenesis and diagnosis of COVID-19
Li, X., Geng, M., Peng, Y., Meng, L., & Lu, S. (2020) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2020.03.001 · Cited by 1,721
Gender differences in the utilization of health care services.
Bertakis, K. D., Azari, R. S., Helms, L., Callahan, E. J., & Robbins, J. A. (2000) · PubMed · Cited by 1,464
Impact of sex and gender on COVID-19 outcomes in Europe
Gebhard, C., Regitz-Zagrosek, V., Neuhauser, H. K., Morgan, R., & Klein, S. L. (2020) · Biology of Sex Differences · doi:10.1186/s13293-020-00304-9 · Cited by 1,306
Hu, S., Marshall, C., Darby, J., Wei, W., Lyons, A. B., & Körner, H. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00001 · Cited by 973
Sex-Based Differences in Susceptibility to Severe Acute Respiratory Syndrome Coronavirus Infection
Channappanavar, R., Fett, C., Mack, M., Ten Eyck, P. P., Meyerholz, D. K., & Perlman, S. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601896 · Cited by 871
Vermeulen, A., Kaufman, J. M., Goemaere, S., & Van Pottelberg, I. (2002) · The Aging Male · doi:10.1080/tam.5.2.98.102 · Cited by 452 · cited 1×
“Although estrogen concentrations in men are about 200 times lower than that of testosterone, over the age of 50, they are higher than the concentrations in postmenopausal women [53].”
BackgroundCoronavirus COV-19/SARS-CoV-2 affects women less than men: clinical response to viral infection.
Conti, P. (2020) · JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS · doi:10.23812/editorial-conti-3 · Cited by 442
The X chromosome and sex-specific effects in infectious disease susceptibility
Schurz, H., Salie, M., Tromp, G., Hoal, E. G., Kinnear, C. J., & Möller, M. (2019) · Human Genomics · doi:10.1186/s40246-018-0185-z · Cited by 405
Gemmati, D., Bramanti, B., Serino, M. L., Secchiero, P., Zauli, G., & Tisato, V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103474 · Cited by 395
Testosterone Acts Directly on CD4+ T Lymphocytes to Increase IL-10 Production
Liva, S. M., & Voskuhl, R. R. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.4.2060 · Cited by 394
Renin angiotensin system and gender differences in the cardiovascular system
Fischer, M. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00479-5 · Cited by 384
Korean Society of Infectious Diseases, Korean Society of Pediatric Infectious Diseases, Korean Society of Epidemiology, Korean Society for Antimicrobial Therapy, Korean Society for Healthcare-associated Infection Control and Prevention, & Prevention, K. C. F. D. C. A. (2020) · Journal of Korean Medical Science · doi:10.3346/jkms.2020.35.e112 · Cited by 382
Sex Bias in Infectious Disease Epidemiology: Patterns and Processes
Guerra-Silveira, F., & Abad-Franch, F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062390 · Cited by 327
Kim, K. H., Tandi, T. E., Choi, J. W., Moon, J. M., & Kim, M. S. (2017) · Journal of Hospital Infection · doi:10.1016/j.jhin.2016.10.008 · Cited by 296
Glucocorticoids, Sex Hormones, and Immunity
Bereshchenko, O., Bruscoli, S., & Riccardi, C. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01332 · Cited by 261
Sex and Gender Differences in Myocardial Hypertrophy and Heart Failure
Regitz-Zagrosek, V., Oertelt-Prigione, S., Seeland, U., & Hetzer, R. (2010) · Circulation Journal · doi:10.1253/circj.cj-10-0196 · Cited by 192
Backhaus, E., Berg, S., Andersson, R., Ockborn, G., Malmström, P., Dahl, M., Nasic, S., & Trollfors, B. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-1648-2 · Cited by 174
Female chromosome X mosaicism is age-related and preferentially affects the inactivated X chromosome
Machiela, M. J., Zhou, W., Karlins, E., Sampson, J. N., Freedman, N. D., Yang, Q., Hicks, B., Dagnall, C., Hautman, C., Jacobs, K. B., et al. (2016) · Nature Communications · doi:10.1038/ncomms11843 · Cited by 167
GREEN, M. S. (1992) · International Journal of Epidemiology · doi:10.1093/ije/21.2.381 · Cited by 163
Self-citationDudel, C., Riffe, T., Acosta, E., van Raalte, A., Strozza, C., & Myrskylä, M. (2020) · PLOS ONE · doi:10.1371/journal.pone.0238904 · Cited by 147
Sex Differences in Case Fatality Rate of COVID-19: Insights From a Multinational Registry
Alkhouli, M., Nanjundappa, A., Annie, F., Bates, M. C., & Bhatt, D. L. (2020) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2020.05.014 · Cited by 146
Expression of ACE2, the SARS-CoV-2 Receptor, and TMPRSS2 in Prostate Epithelial Cells
Song, H., Seddighzadeh, B., Cooperberg, M. R., & Huang, F. W. (2020) · European Urology · doi:10.1016/j.eururo.2020.04.065 · Cited by 140
Trends and Patterns of Differences in Infectious Disease Mortality Among US Counties, 1980-2014
Bcheraoui, C. E., Mokdad, A. H., Dwyer‐Lindgren, L., Bertozzi-Villa, A., Stubbs, R. W., Morozoff, C., Shirude, S., Naghavi, M., & Murray, C. J. L. (2018) · JAMA · doi:10.1001/jama.2018.2089 · Cited by 132
Emerging markers in cardiovascular disease: Where does angiotensin‐converting enzyme 2 fit in?
Patel, S. K., Velkoska, E., & Burrell, L. M. (2013) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12069 · Cited by 131
Sex Differences in Measles Mortality: A World Review
Garenne, M. (1994) · International Journal of Epidemiology · doi:10.1093/ije/23.3.632 · Cited by 111
Seillet, C., Rouquié, N., Foulon, E., Douin‐Echinard, V., Krust, A., Chambon, P., Arnal, J., Guéry, J., & Laffont, S. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203312 · Cited by 107
Sex-hormone-driven innate antibodies protect females and infants against EPEC infection
Zeng, Z., Surewaard, B. G. J., Wong, C. H. Y., Guettler, C., Petri, B., Burkhard, R., Wyss, M., Le Moual, H., Devinney, R., Thompson, G. C., et al. (2018) · Nature Immunology · doi:10.1038/s41590-018-0211-2 · Cited by 96 · cited 1×
“In addition, mortality rates from sepsis appear to be lower in females [34] and there appears to be a more efficient immune response to gramnegative bacteria in female mice [35].”
BackgroundCase fatality of SARS in mainland China and associated risk factors
Jia, N., Feng, D., Fang, L., Richardus, J. H., Xiao-na, H., Cao, W., & de Vlas, S. J. (2009) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2008.02147.x · Cited by 87
Klein, S. L., Marks, M. A., Li, W., Glass, G. E., Fang, L.-Q., Ma, J.-Q., & Cao, W.-C. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir232 · Cited by 83
Ancochea, J., Izquierdo-Alonso, J. L., & Soriano, J. B. (2021) · Journal of Women s Health · doi:10.1089/jwh.2020.8721 · Cited by 78
Sex and Gender Differences in Cardiovascular Drug Therapy
Seeland, U., & Regitz‐Zagrosek, V. (2012) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-30726-3_11 · Cited by 76
Sex Differences in Clinical Leptospirosis in Germany: 1997-2005
Jansen, A., Stark, K., Schneider, T., & Schöneberg, I. (2007) · Clinical Infectious Diseases · doi:10.1086/513431 · Cited by 73
SARS‐CoV‐2, testosterone and frailty in males (PROTEGGIMI): A multidimensional research project
Salonia, A., Corona, G., Giwercman, A., Maggi, M., Minhas, S., Nappi, R. E., Sofikitis, N., & Vignozzi, L. (2020) · Andrology · doi:10.1111/andr.12811 · Cited by 66
Comparison of COVID-19 infections among healthcare workers and non-healthcare workers
Kim, R. C., Nachman, S., Fernandes, R., Meyers, K. E., Taylor, M., LeBlanc, D., & Singer, A. J. (2020) · PLoS ONE · doi:10.1371/journal.pone.0241956 · Cited by 62
Sex Differences in HIV Outcomes in the Highly Active Antiretroviral Therapy Era: A Systematic Review
Castilho, J. L., Melekhin, V. V., & Sterling, T. R. (2014) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2013.0208 · Cited by 61
Xia, H., Zhang, G., Wang, R.-R., & Zheng, Y. (2009) · Cellular and Molecular Immunology · doi:10.1038/cmi.2009.55 · Cited by 60
Kahlke, V., Dohm, C. P., Mees, T., tzmann, K. B., Schreiber, S., & Schr??der, J. (2002) · Shock · doi:10.1097/00024382-200207000-00005 · Cited by 54
Estimating case fatality rates of COVID-19
Lipsitch, M. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30245-0 · Cited by 47
Epidemiological Measures in the Context of the COVID-19 Pandemic
Gianicolo, E., Riccetti, N., Blettner, M., & Karch, A. (2020) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2020.0336 · Cited by 44
Green, M. S., Peer, V., Schwartz, N., & Nitzan, D. (2020) · PLoS ONE · doi:10.1371/journal.pone.0241031 · Cited by 39
Self-citationPeer, V., Schwartz, N., & Green, M. S. (2020) · PLoS ONE · doi:10.1371/journal.pone.0231570 · Cited by 32
Self-citationEstimating case fatality rates of COVID-19
Kim, D. D., & Goel, A. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30234-6 · Cited by 31
Gupta‐Wright, A., Fielding, K., Wilson, D., van Oosterhout, J. J., Grint, D. J., Mwandumba, H. C., Moyo, M., Peters, J. A., Chiume, L., Lawn, S. D., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz1133 · Cited by 29
Does access to medicines differ by gender? Evidence from 15 low and middle income countries
Stephens, P. N., Ross‐Degnan, D., & Wagner, A. K. (2013) · Health Policy · doi:10.1016/j.healthpol.2013.01.016 · Cited by 12
Publications from International Organizations on Public Health
Barbaro, A. (2020) · Annali dell Istituto Superiore di Sanità · doi:10.4415/ann_21_03_11 · Cited by 1
Research works printed but not linked: 3
- A Dictionary of Epidemiology. Edited by Miquel Porta. Oxford University Press. 6th Edition. 2014.
- S Ravi, 2020, COVID-19 trends from Germany show different impacts by gender and age
- A Gupta-Wright, 2019, Tuberculosis in hospitalised patients with HIV: clinical characteristics, mortality, and implications from the STAMP trial, Clin Infect Dis, ciz1133
Cited by
Gender Differences in Adverse Events Following the Pfizer-BioNTech COVID-19 Vaccine
Green, M. S., Peer, V., Magid, A., HaGani, N., Anis, E., & Nitzan, D. (2022) · Vaccines · doi:10.3390/vaccines10020233 · Cited by 118
Self-citationSex hormones in SARS-CoV-2 susceptibility: key players or confounders?
Lott, N., Gebhard, C. E., Bengs, S., Haider, A., Kuster, G. M., Regitz‐Zagrosek, V., & Gebhard, C. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00780-6 · Cited by 43
Esmaeili, E. D., Fakhari, A., Naghili, B., Khodamoradi, F., & Azizi, H. (2022) · Journal of Medical Virology · doi:10.1002/jmv.27594 · Cited by 27
Malani, A., & Ramachandran, S. (2022) · Journal of Development Economics · doi:10.1016/j.jdeveco.2022.102988 · Cited by 24
Study of Post-COVID-19 Syndrome in Saudi Arabia
Mahmoud, M. H., Alghamdi, F. A., Alghamdi, G. A., Alkhotani, L. A., Alrehaili, M. A. M., & Eldeeb, D. (2021) · Cureus · doi:10.7759/cureus.17787 · Cited by 24
Metadata
- Authors
- Green, M. S., Nitzan, D., Schwartz, N., Niv, Y., & Peer, V.
- Affiliations
- University of Haifa (IL)
- World Health Organization - Denmark (DK)
- Israel Ministry of Health (IL)
- Corresponding author
- Green, Manfred S.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2021-04-29
- Volume
- 16
- Issue
- 4
- Pages
- e0250523
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC8084161
- OpenAlex
- W3157347494
- Cited by
- 52
- References
- 51
- Citations by year
- 2026: 1 · 2025: 6 · 2024: 10 · 2023: 10 · 2022: 15 · 2021: 10
- FWCI
- 3.56
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- World Health Organization
- Topics
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Physical Sciences › Mathematics › Modeling and Simulation › COVID-19 epidemiological studies
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Sex and Gender in Healthcare
- Keywords
- COVID-19 pandemic, case fatality rate, sex differences, age-specific mortality, sex differences in disease severity, cross-national comparison, underlying disease
- MeSH terms
- COVID-19, SARS-CoV-2, Adolescent, Adult, Age Factors, Aged, Aged, 80 and over, Canada, Child, Child, Preschool, England, Europe, Female, Humans, Infant, Israel, Male, Mexico, Middle Aged, Retrospective Studies, Sex Factors, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.